MktsMarkets

Jasper Therapeutics, Inc.
NASDAQ: JSPRKey statistics
JSPR News
Stories mentioning JSPR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | 3,623 | 9,345 | 9,760 | 8,784 | ||||
| Gross Profit | (3,623) | (22,530) | (9,345) | 0.00 | (9,760) | (25,484) | (8,784) | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 5,814 | 11,360 | 14,391 | 21,196 | 16,157 | 19,772 | 14,455 | 11,296 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 10,952 | 15,839 | 19,166 | 27,076 | 21,802 | 25,285 | 19,889 | 15,993 |
| Operating Income (Loss) | (10,952) | (15,839) | (19,166) | (27,076) | (21,802) | (25,285) | (19,889) | (15,993) |
| Interest Income | 164.00 | 338.00 | 342.00 | 437.00 | 624.00 | 938.00 | 1,284 | 1,450 |
| Interest Expense | ||||||||
| Other Expense | (26.00) | (29.00) | (2,011) | (84.00) | (63.00) | 26.00 | (32.00) | (40.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (1,174) | (9,101) | (18,736) | (26,723) | (21,241) | (24,321) | (18,637) | (14,583) |
| Earnings Per Share (Basic) | (0.04) | (0.47) | (1.13) | (1.74) | (1.41) | (1.67) | (1.24) | (0.97) |
| Earnings Per Share (Diluted) | (0.04) | (0.47) | (1.13) | (1.74) | (1.41) | (1.67) | (1.24) | (0.97) |
| Weighted Average Shares Outstanding (Basic) | 28,672 | 19,168 | 16,636 | 15,334 | 15,022 | 14,585 | 15,001 | 14,986 |
| Weighted Average Shares Outstanding (Diluted) | 28,672 | 19,168 | 16,636 | 15,334 | 15,022 | 14,585 | 15,001 | 14,986 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About JSPR
Jasper Therapeutics, Inc. (NASDAQ: JSPR) is a stock listed on the Nasdaq Stock Market under the ticker symbol JSPR. It last traded at $13.68 (Nov 13, 2026, 4:00 PM ET), up 2.3% on the day. That gives Jasper Therapeutics a market capitalisation of $14.9M.
Over the past 52 weeks JSPR has traded between $9.45 and $72.60.
For the quarter ended Mar 31, 2026 it reported a net loss of $1.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$1.2M |
| Dec 31, 2025 | — | -$9.1M |
| Sep 30, 2025 | — | -$18.7M |
| Jun 30, 2025 | — | -$26.7M |
From Jasper Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…